Predicting prognosis in hepatocellular carcinoma (HCC) aids clinical decision-making and stratifies patient follow-up plans. There are currently three prognostic scores specific to liver resection of HCC published in the literature: the MSKCC, SLICER and SSCLIP scores. In this review, we highlight the methodology employed in the construction of these scores and discuss the strengths and weaknesses of each. Current limitations to prognostic scores include the inability to differentiate between early and late recurrences of HCC, the failure to account for the impact of aetiology of HCC and the assumption that ethnicity has no impact on disease process. Further scientific discoveries in these areas will allow for improvement in prognostication. The SLICER score is currently the most comprehensive. External validation of each score in cohorts of patients with different baseline demographics and clinical characteristics will be required to examine their stability and reliability.
Introduction
Hepatocellular carcinoma (HCC) is the sixth most common cancer in the world, and is often associated with a poor prognosis and a high burden of morbidity and mortality (1) . Currently, surgical resection remains the major curative therapeutic option in patients with adequate residual liver function, whilst liver transplantation offers the best long-term outcome in patients who do not have adequate liver function reserve. Yet, despite successful surgical resection, the risk of relapse is extremely high with a 5-year tumour recurrence rate of up to 70% (2) . This highlights the need for a good prognostic score in guiding management and stratification of patients post-surgical resection.
Many scores have been developed for classification, staging and/ or prognostication of HCC, such as the American Joint Committee on Cancer staging system 7th edition 2009, Barcelona Clinic Liver Cancer, Cancer of the Liver Italian Program (CLIP), Chinese University Prognostic Index, International Hepato-Pancreato-Biliary Association staging system, Japan Integrated Staging score, Okuda score and the Vauthey staging system (3) (4) (5) (6) (7) (8) (9) (10) (11) . Although some of these systems have been used in the prognostication of patients postoperatively, these systems have been predominantly derived from patients with a wide spectrum of disease stages, including those with metastatic or locally advanced disease, often with coexisting impaired liver function. Given that the clinical outcomes of patients with HCC are dependent on the treatment received (12) , this review seeks to compare the different prognostic scoring systems currently available that is specific for HCC patients post-surgical resection.
A search of the literature revealed that three prognostic tools have been developed to specifically evaluate the outcome of HCC patients post-surgical resection in terms of relapse prediction and survival. These are a prognostic nomogram developed at Memorial Sloan-Kettering Cancer Centre by Cho et al. (13) Li et al. (16) and the other in predicting HCC recurrence after liver transplantation by Agopian et al. (17) . This review will focus on prognostic scoring systems for relapse prediction and overall survival after liver resection in HCC, and as such will focus on comparing the three scores available, namely the MSKCC, SLICER and SSCLIP scores, highlighting the strengths and weaknesses of each.
Comparison of patient cohorts
The MSKCC and SLICER scoring systems were generated using a single series of patients, whilst the SSCLIP utilized both a training and a validation cohort. The MSKCC, SLICER and SSCLIP training cohorts comprise patients from a single institution, whilst the SSCLIP validation cohort utilized patient data from four institutions. The SSCLIP study comprises the largest group of patients; with a total of 668 patients included in both cohorts (281 in training cohort and 387 in validation cohort). The MSKCC and SLICER studies included 184 and 405 patients, respectively. Data were collected retrospectively in SLICER and SSCLIP but prospectively in MSKCC.
The main inclusion criteria for all three studies were patients who had undergone liver resection for HCC, diagnosis of which was confirmed on histopathological examination of the resected specimen.
Only MSKCC excluded patients with fibrolamellar HCC. Whilst the number of such patients is small, fibrolamellar HCC is known to have more indolent tumour biology when compared with standard HCC (18) , and inclusion will serve as a confounder. The SLICER study only included patients who underwent hepatic resection as first-line treatment for HCC whilst in the MSKCC study 7% underwent some form of preoperative neoadjuvant chemotherapy and 3% underwent postoperative adjuvant chemotherapy. The SSCLIP study excluded patients who had a previous history of percutaneous ethanol injection, radiofrequency ablation, transarterial chemoembolization or liver transplantation. As clinical outcomes in HCC patients are highly dependent on the treatment received (12) , inclusion of patients with modalities of treatment apart from surgical resection introduces avoidable confounding factors.
A comparison of the baseline demographic and clinical characteristics of each cohort is presented in Table 1 . The ethnic composition of patients in the SLICER study was predominantly Chinese (92.6%) but in the MSKCC study was predominantly Caucasian (61%) with a smaller percentage of Asians (28%). The racial distribution for the SSCLIP study was not stated; however, the locations of all the participating institutions were in China, suggesting that the ethnic composition of patients was predominantly Chinese (19) . With regard to viral hepatitis status, 62.5% of patients were positive for Hepatitis B, Hepatitis C or both in the SLICER cohort, whilst this figure was 85.3% and 84.6% in the training cohort and validation cohort of SSCLIP, respectively; this data were not available in the MSKCC paper. The proportion of patients with Child-Pugh A status was the highest in the MSKCC study (96%), followed by the SLICER study (89.9%) then the SSCLIP study (82.4%). Histology grade was predominantly moderately differentiated (Grade II/III) and this was 83.3% in the SLICER study and 56% in the MSKCC study. Details on the aforementioned characteristics would be useful in giving further consideration and weightage to factors influencing the aetiology (genetic factors, viral status, background field change) and tumour biology of HCC, important factors which may affect prognosis.
Comparison of score construction and statistical analysis
Two of the developed prognostic scores are nomograms whilst one is a numerical score. The score construction and data analysis of the nomogram scores are not directly comparable with the numerical score.
The SLICER and MKSCC groups constructed nomograms to calculate the likelihood of 3-and 5-year freedom from recurrence (FFR) (Figs 1 and 2 ). In addition, the MSKCC group constructed a separate nomogram to determine the likelihood of 3-and 5-year survival (Fig. 3) . Kaplan-Meier survival curves were used to estimate FFR and survival outcomes in both papers. The SLICER group subjected the various clinicopathologic variables to univariate Cox regression to evaluate the effects on FFR whilst the MKSCC group carried out univariate analysis using log-rank test for categorical variables and Cox regression for continuous variables. The MSKCC group incorporated the informative prognostic variables identified into a predictive modelling system to construct the HCC survival nomogram and HCC FFR nomogram. The SLICER group on the other hand conducted clustering of variables to reduce the number of potential prognostic factors by evaluating the similarity between factors, using Hoeffding distance to measure correlation. They then performed reduced model selection using a backward stepdown by applying the Akaike information criterion and subsequently proportional hazard assumptions were verified systematically for all the proposed models. The final multivariable Cox regression coefficients were then used to construct the SLICER nomogram. Both scores underwent internal validation to evaluate the ability of the nomogram to predict FFR/survival with 200 bootstrap samples. Calibration plots were then generated to explore the performance characteristics of the nomograms at 3-and 5-year post-resection. The SLICER group also performed decision curve analyses (20) to evaluate the predictive models by examining the theoretical relation between the threshold probability of developing an event and the relative value of falsepositive or false-negative results.
The SSCLIP scoring system (Table 2 ) was developed by modifying the original CLIP scoring system (5,6) to include an additional four variables. The differences in categorical data were analysed using the Chi-square test of Fisher's exact test as appropriate, whilst the differences in continuous variables were analysed using the Mann-Whitney U test. Univariate Cox proportional hazards regression analysis was performed in the training cohort to identify covariates with univariate significance. The significant variables were then included in a multivariate Cox proportional hazards regression analysis to identify independent prognostic predictors. Four independent predictors were identified, namely age, albumin, prothrombin time activity (PTA) and microvascular invasion. Receiver operating characteristics (ROCs) analysis was used to identify possible predictive cut-off values for age and albumin. The cut-off value for PTA was identified according to the Asian-Pacific Association for The Study of Liver Guideline.
ROC analyses were performed in the training cohort to assess the ability of the SSCLIP score in predicting 1-and 3-year mortality risks. The authors then divided the score of the SSCLIP into three categories which were low risk (0-2), intermediate risk (3) (4) (5) and high risk (≥6). Chi-square test analysis comparing patients with Figure 1 . SLICER score nomogram for hepatocellular carcinoma (HCC) recurrence. To use the nomogram, locate the first variable. Draw a line straight upwards to the Points axis to determine the number of points received for the variable. Repeat this process for other six variables and sum up the points achieved for each variable. The sum of these numbers is located on the Total Points axis, and a line is drawn downward to the survival axes to determine the likelihood of 3-or 5-year freedom from recurrence (FFR). For example, a patient who has a 3 cm HCC with multifocality, liver cirrhosis, Child-Pugh A, minor vascular invasion, resection margin 5 mm, pre-surgery α-fetoprotein (AFP) 450 ng/ml and he was asymptomatic at presentation, total points scored is 48. Three-and 5-year FFR is 16 and 8%, respectively. Taken from Ang et al. (14) . Reproduced from PLOS ONE -open access. different risk levels was done in the training cohort and in the validation cohort.
A P value of <0.05 was considered statistically significant in all papers. Comparisons of the methodologies employed are summarized in Table 3 .
Comparison of score criteria and results
The clinical outcome for the SLICER study was FFR and for the SSCLIP study, death; whilst the MSKCC study looked at both outcomes. All three prognostic scores included preoperative α-fetoprotein (AFP) levels, the presence of vascular invasion and tumour size as common variables, identifying these variables as strong independent predictors of outcome following curative liver resection, as suggested by evidence in the literatures (21) (22) (23) .
In the MSKCC study, the results of univariate analysis identified vascular invasion (0.0008), the presence of tumour-related symptoms (0.0009), satellitosis (0.0016), portal vein thrombosis (0.0016), >50% hepatic parenchymal involvement (0.002), bilobar involvement (0.0032), size >5 cm (0.015) and extrahepatic invasion of adjacent anatomic structures (0.011) as categorical variables and estimated blood loss (0.0001), albumin (0.001), tumour size (0.015) and age (0.016) as continuous variables associated with worse overall survival (P value in brackets, all <0.05). However, out of the aforementioned variables, only age, estimated blood loss, satellitosis, vascular invasion and tumour size >5 cm were included as criteria in the nomogram. In addition, two other criteria included in the nomogram, margin positivity (P = 0.15) and AFP levels (P = 0.43) did not have significant P values.
The selection of variables to be included in the nomogram was more robust in the SLICER study as clustering and reduced model selection was performed to identify the final variables to be included in the nomogram. All P values for the variables selected for the SLICER nomogram construction were <0.05 on univariate analysis and ranged between <0.0001 and 0.662 on multivariable analysis. However, the SLICER score which was developed 7 years after the MSKCC score had the benefit of evaluating the latter and improve on any inherent shortcomings.
The relative strengths of the SSCLIP study were that it had two separate training and validation cohorts, comprising patients from a total of five different institutions in the country, when compared with single institution in the SLICER and MSKCC studies. The SSCLIP score was modified based on the CLIP and the SSCLIP authors acknowledged that 'to date, it remains controversial whether it (CLIP) is the best model for predicting the prognosis in patients who underwent curative liver resection for HCC' (14) . In addition, the CLIP >41.6 ≤41.6 -Prothrombin time activity (%) ≥40 <40 -Parameters marked with an asterisks are parameters which comprise the original CLIP scoring system. The score range is 0-6 for the original CLIP scoring system and 0-10 for the SSCLIP scoring system. Based on Huang et al. (15) . score was developed in an Italian population whilst the modification of the CLIP to SSCLIP was developed in a Chinese population. The cut-off values for the three continuous variables included in the SSCLIP score were selected by testing different combinations of possible cut-off values after the construction of SSCLIP, either by using ROC analysis or pre-existing suggested cut-off values. In addition, when calculating the sensitivity, specificity, positive predictive value and negative predictive values of the SSCLIP at 12-month and 36-month to demonstrate the diagnostic accuracy of SSCLIP, two different cut-off points were used 3 and 2, respectively.
The Child-Pugh score is determined by bilirubin levels, albumin levels, international normalised ratio (INR), and the presence and severity of ascites and encephalopathy. Child-Pugh class is one of the variables included in the CLIP score and hence also in the SSCLIP score. However, the SSCLIP score includes albumin as a separate variable, resulting in albumin having more than single weightage in the calculated score. Similarly, INR, which is derived from PTA, is used in the calculation of Child-Pugh class, yet PTA is a separate variable included in the SSCLIP score. Whilst not ideal, this is common in clinical practice and may be permissible.
The SSCLIP score and most of the other systems currently in use permit differentiation of statistically distinct risk categories. However, the high degree of heterogeneity in the tumour biology of HCC and within each risk category hinders predictive modelling of survival outcomes on an individual basis. Nomograms such as those developed by the MSKCC and SLICER groups may allow for a more patienttailored approach and permit more refined risk estimation for each individual. A minor drawback to using a nomogram when compared with a simple scoring system is the complexity and two-step approach in calculating the scores and subsequently probabilities, but this can be overcome by the creation of applications that could be used on a personal mobile device or computer in the clinical setting.
Discussion
The MSKCC, SLICER and SSCLIP groups all reported better performance of their proposed score compared with conventional HCC prognostic models previously published. This is intuitive as all patients had a common modality of treatment, i.e. some form of liver resection whereas conventional scores were developed from patient cohorts who were administered a variety of therapies including palliative care. Patients suitable for liver resection are more uniform and would have adequate liver function reserve, demonstrated by the majority of patients in all three studies being of Child-Pugh Class A status (Table 1) .
Current limitations in the prognostic scoring systems
Evidence in the literature suggests that early and late recurrences of HCC are to be considered differently, with early recurrence possibly resulting from metastasis of the same primary tumour and late recurrence as a result of de novo tumours arising on a background of field change (24, 25) . It has been suggested that the optimal cutoff between early and late recurrences is 17 months (26) . Although all scoring systems have included variables that may account for tumour characteristics (e.g. vascular invasion, multifocality, tumour size), only the SLICER and SSCLIP scores included variables that may have a possible effect on field change (liver cirrhosis and ChildPugh score). However, in all scores no distinction was made in calculating the probabilities of early and late recurrences, which may affect the intensity of clinical surveillance and adjuvant therapy post-operatively.
Another important characteristic which was not given enough weight in the three papers was the aetiology of HCC. Although the SLICER study and the SSCLIP study looked at viral hepatitis status, this variable was not included as a criterion in either scoring systems. Hepatitis B and C is prevalent in the Asia, Africa and Western Pacific regions and is the most common aetiology for HCC in these regions (25) . Patient survival is higher and HCC recurrence rates are lower in patients with hepatitis B compared to those with hepatitis C (27); a possible explanation for this could be that different viral aetiologies may activate different cell signalling pathways in distinct ways (28) . The inclusion of viral hepatitis status in a prognostic score could increase the performance and calibration of the score. Equally important would be to look at other less common risk factors such as alcoholic liver disease, non-alcoholic steatohepatitis, intake of aflatoxin-contaminated food, diabetes and obesity which may play a major role in other racial populations (29) .
There are currently no published studies that directly compare the effect of ethnicity on HCC apart from genetic studies. A recently published paper by Totoki et al. (28) examined the global landscape of genetic changes in the HCC genome arising from different ancestral backgrounds. This study identified unique mutational signatures that contribute more to Asian cases of HCC than to ones of European ancestry, suggesting that certain ethnicities or genetic variations therein may predispose to HCC. Further research may elucidate the fundamental homologies or genetic differences between ethnicities that underpin HCC development and how they contribute to prognostication of this disease.
Conclusion
To date, three prognostic scoring systems for HCC after liver resection have been described. The SSCLIP score is useful as a quick tool for stratification, whilst the SLICER and MSKCC nomograms provide more individualized scores. The MSKCC nomogram was the first prognostic score developed and the SLICER score that was developed later had the benefit of evaluating the MSKCC score and was based on a larger cohort of patients. The SLICER score is also methodologically more robust and would be the most informative score.
A longer duration of follow-up and external validation in cohorts of patients with different baseline demographics and clinical characteristics will be required to conclusively examine the stability and reliability of each score. Further research and consideration of genomic and molecular pathways of HCC would lead to more accurate prognostic scoring systems in the future.
